Dana-Farber/Mass General Brigham Cancer Care, Inc. is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Dana-Farber/Mass General Brigham Cancer Care, Inc. has participated in 1 clinical trials.
Therapeutic areas: Non-Hodgkin Lymphoma.
Sponsors: Gamida Cell ltd.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber/Mass General Brigham Cancer Care, Inc. has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber/Mass General Brigham Cancer Care, Inc. has 1 clinical trials on record. Their work covers Non-Hodgkin Lymphoma.
Dana-Farber/Mass General Brigham Cancer Care, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.